Tony Butler
Stock Analyst at Rodman & Renshaw
(0.87)
# 3,243
Out of 4,667 analysts
99
Total ratings
28.05%
Success rate
-21.21%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $6.48 | +177.78% | 4 | Sep 26, 2024 | |
| MURA Mural Oncology | Initiates: Buy | $15 | $3.38 | +343.34% | 1 | Jun 28, 2024 | |
| LPTX Leap Therapeutics | Initiates: Buy | $8 | $2.60 | +207.69% | 1 | Jun 28, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $1.24 | +1,195.55% | 5 | Aug 10, 2023 | |
| ADAP Adaptimmune Therapeutics | Reiterates: Buy | $10 | $0.64 | +1,456.90% | 8 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $2.04 | +390.20% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $46.51 | +61.26% | 8 | Aug 8, 2023 | |
| MRUS Merus | Reiterates: Buy | $35 | $44.66 | -21.62% | 7 | Aug 8, 2023 | |
| GTBP GT Biopharma | Reiterates: Hold | $60 | $3.01 | +1,896.67% | 5 | Aug 7, 2023 | |
| CGEN Compugen | Reiterates: Buy | $13 | $1.51 | +763.79% | 6 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $20.19 | +147.65% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.11 | +610.90% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.43 | +1,644.35% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $2.17 | +592.84% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.15 | +6,566.67% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.61 | +1,550.17% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $3.40 | +400.00% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $2.85 | +5,724.56% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $11.10 | +440.78% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.35 | +2,186.37% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.84 | +614.29% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $9 | $0.76 | +1,090.32% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $17 | $0.70 | +2,325.11% | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $625 | $10.30 | +5,967.96% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $4.65 | +222.57% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $3.00 | +233.33% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.39 | +983.03% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $14.25 | +671.93% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.29 | +6,125.68% | 1 | Mar 2, 2020 |
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $6.48
Upside: +177.78%
Mural Oncology
Jun 28, 2024
Initiates: Buy
Price Target: $15
Current: $3.38
Upside: +343.34%
Leap Therapeutics
Jun 28, 2024
Initiates: Buy
Price Target: $8
Current: $2.60
Upside: +207.69%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $1.24
Upside: +1,195.55%
Adaptimmune Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $10
Current: $0.64
Upside: +1,456.90%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $2.04
Upside: +390.20%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $46.51
Upside: +61.26%
Merus
Aug 8, 2023
Reiterates: Buy
Price Target: $35
Current: $44.66
Upside: -21.62%
GT Biopharma
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $3.01
Upside: +1,896.67%
Compugen
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $1.51
Upside: +763.79%
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $20.19
Upside: +147.65%
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $2.11
Upside: +610.90%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $1.43
Upside: +1,644.35%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $2.17
Upside: +592.84%
Jul 31, 2023
Initiates: Buy
Price Target: $10
Current: $0.15
Upside: +6,566.67%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $0.61
Upside: +1,550.17%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $3.40
Upside: +400.00%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $2.85
Upside: +5,724.56%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $11.10
Upside: +440.78%
Jun 5, 2023
Reiterates: Buy
Price Target: $8
Current: $0.35
Upside: +2,186.37%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.84
Upside: +614.29%
Jun 1, 2023
Assumes: Buy
Price Target: $9
Current: $0.76
Upside: +1,090.32%
May 25, 2023
Assumes: Buy
Price Target: $17
Current: $0.70
Upside: +2,325.11%
Jan 5, 2023
Initiates: Buy
Price Target: $625
Current: $10.30
Upside: +5,967.96%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $4.65
Upside: +222.57%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $3.00
Upside: +233.33%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $1.39
Upside: +983.03%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $14.25
Upside: +671.93%
Mar 2, 2020
Initiates: Buy
Price Target: $80
Current: $1.29
Upside: +6,125.68%